Missing/wrong data?
Log in to edit
Head-to-head comparison of certolizumab pegol versus adalimumab in rheumatoid arthritis: 2-year efficacy and safety results from the randomised EXXELERATE study
scientific article published on 11 November 2016
Author/s
author: Gerd-Rüdiger Burmester, Christopher Cioffi, Cécile Ecoffet, Leon Gervitz, Ronald van Vollenhoven, Josef S Smolen, Jeffrey R Curtis, Bernard Combe, Boulos Haraoui
Work details
Publication date
November 11, 2016
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.